Center for HIV/AIDS Vaccine Immunology (CHAVI)

The summary for the Center for HIV/AIDS Vaccine Immunology (CHAVI) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Center for HIV/AIDS Vaccine Immunology (CHAVI)
	CFDA Number:	93.855
	CFDA Description:	Allergy, Immunology and Transplantation Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-04-051
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Oct 05, 2004
	Creation Date:	Oct 05, 2004
	Original Closing Date for Applications:	Feb 23, 2005
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Mar 25, 2005
	Expected Number of Awards:	1
	Estimated Total Program Funding:	$14,900,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible agencies of the Federal Government are eligible to apply. Foreign Institutions are not eligible however foreign collaborations are encouraged.
Grant Description: NIAID seeks to establish a Center for HIV/AIDS Vaccine Immunology (CHAVI) that will support intensive and highly collaborative projects addressing key immunological roadblocks to the discovery and development of a safe and effective HIV vaccine as defined by NIAID and identified by the Global HIV Vaccine Enterprise. Over the 7-year project period the research to be designed and conducted by CHAVI will address: (1) the elucidation of (a) early immunologic and virologic events after HIV-1 infection in humans, and/or (b) immune correlates for protection in animal models; (2) the systematic design and evaluation of immunogens and adjuvants eliciting persistent mucosal and/or systemic immune responses; and (3) the evaluation of vaccine candidates in early phase clinical trials. First year funding will support a CHAVI Director and the awardee institution for (1) the further development and initial implementation of a Scientific Agenda and Strategic Plan for ! all CHAVI activities; (2) the Management and Operations resources to coordinate and manage the entire range of CHAVI activities; (3) research, to be undertaken by the CHAVI Director and investigators in the CHAVI Scientific Leadership Group, focusing on: elucidation of early immunologic and virologic events after HIV infection, and/or elucidation of correlates of immune protection in non-human primate models; as well as initiating the systematic evaluation of vaccine candidates and immunization strategies to enhance mucosal immunity, potency, antigen presentation and immunogenicity; and (4) the development of scientific resources and facilities essential to implement the Scientific Agenda. Expanded funding in the second and subsequent years will support additional research and additional investigators to fully implement the CHAVI Scientific Agenda.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-051.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-051.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants: • Innovation for HIV Vaccine Discovery (R01); • NIAID Clinical Trial Implementation Cooperative Agreement (U01); • Therapeutics for Neurotropic Biodefense Toxins and Pathogens (R21/R33); • Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01); • Predictive Biodosimetry: Discovery and Development of Biomarkers for Acute and Delayed Radiation Inj...; • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers; • Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01); • Asthma and Allergic Diseases Cooperative Research Centers (U19); • Medical Countermeasures to Restore Gastrointestinal Function after Radiation Exposure: Project Biosh...